GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: DF2726 (acid form) | DF2726A (sodium salt)
Compound class:
Synthetic organic
Comment: DF2726 is a non-competitive, negative allosteric modulator of CXCL8 (IL-8) signalling via its endogenous chemokine receptors CXCR1 and CXCR2 [1]. Its chemical structure was claimed in patent EP3192504A1 [2], and it appears to be structurally related to DF2755A. Activation of the IL-8 pathway has been linked to the development of chemotherapy-induced neuropathic pain. It is predicted that inhibition of this mechanism might offer clinical utility for cancer patients who experience chemotherapy-induced peripheral neuropathy [1].
DF2726A refers to the sodium salt formulation that is used for in vitro and in vivo studies. |
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 2-methyl-2-[4-[[4-(trifluoromethyl)-1,3-thiazol-2-yl]amino]phenyl]propanoic acid |
Synonyms ![]() |
| DF2726 (acid form) | DF2726A (sodium salt) |
Database Links ![]() |
|
| GtoPdb PubChem SID | 473153819 |
| PubChem CID | 45110930 |
| Search Google for chemical match using the InChIKey | TVKXUJXIOMUVFS-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | TVKXUJXIOMUVFS |
| UniChem Compound Search for chemical match using the InChIKey | TVKXUJXIOMUVFS-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | TVKXUJXIOMUVFS-UHFFFAOYSA-N |